NCT06898593 Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
| NCT ID | NCT06898593 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Condition | Anxiety Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,448 participants |
| Start Date | 2025-04-02 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,448 participants in total. It began in 2025-04-02 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if adding patients' goals and concerns to measurement-based collaborative care can tailor care and provide a more holistic view of treatment, thereby improving engagement in care among adult patients receiving collaborative care. The main questions it aims to answer are: * Does using a clinical decision support system (which includes an enhanced pre-visit questionnaire and patient-level dashboard) improve patient engagement in the collaborative care model? * Does using a clinical decision support system improve patient and clinician satisfaction with care? Researchers will compare the enhanced collaborative care with traditional collaborative care. Patient participants will complete pre-visit questionnaires before their collaborative care appointments. Responses will be viewed by the clinician and/or patient in a visual dashboard inside the electronic health record.
Eligibility Criteria
Inclusion Criteria: * Patients enrolled in the Collaborative Care Model (CoCM) at Dartmouth Health Exclusion Criteria: * Patients not enrolled in the Collaborative Care Model (CoCM) at Dartmouth Health
Contact & Investigator
Anna Tosteson, ScD
PRINCIPAL INVESTIGATOR
Dartmouth College
Frequently Asked Questions
Who can join the NCT06898593 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Anxiety Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06898593 currently recruiting?
Yes, NCT06898593 is actively recruiting participants. Contact the research team at irina.perreard@dartmouth.edu for enrollment information.
Where is the NCT06898593 trial being conducted?
This trial is being conducted at Concord, United States, Lebanon, United States, Lebanon, United States, Manchester, United States and 2 additional locations.
Who is sponsoring the NCT06898593 clinical trial?
NCT06898593 is sponsored by Dartmouth-Hitchcock Medical Center. The principal investigator is Anna Tosteson, ScD at Dartmouth College. The trial plans to enroll 2,448 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.